Analysis Group

Analysis Group
Name	Analysis Group
Type	Private
Industry	Consulting
Founded	1981
Founder	Bruce E. Stangle, Michael F. Koehn
Headquarters	Boston, Massachusetts
Key people	Bruce E. Stangle, Peter H. Harkness
Num employees	1,000+ (approx.)

Analysis Group is an economic, financial, and health science consulting firm that provides expert testimony, economic modeling, and strategic advisory services in litigation, regulatory proceedings, and corporate transactions. Founded in Boston in 1981, the firm serves law firms, corporations, and government agencies across sectors including pharmaceuticals, telecommunications, energy, and finance. Its work often intersects with high-profile litigation, regulatory disputes, and merger reviews involving multinational corporations and public institutions.

History

The firm was established in 1981 in Boston by founders with backgrounds at Harvard University, Massachusetts Institute of Technology, and consulting practices serving clients from Federal Trade Commission matters to private dispute resolution. Early engagements involved antitrust matters similar to cases before the United States District Court for the District of Massachusetts and analyses related to Securities and Exchange Commission enforcement. Throughout the 1990s and 2000s the company expanded alongside growth in complex litigation exemplified by proceedings in the United States Court of Appeals for the First Circuit, regulatory reviews at the Federal Communications Commission, and public health debates involving the Food and Drug Administration. The firm opened multiple offices across North America and internationally, responding to demands from law firms such as Kirkland & Ellis, Skadden, Arps, Slate, Meagher & Flom, and Latham & Watkins and corporate clients like Pfizer, AT&T, and ExxonMobil.

Services and Practice Areas

The firm's practice covers economic analysis, financial valuation, damages quantification, biostatistics, epidemiology, and health economics for cases in courts such as the United States Supreme Court, U.S. District Court for the Southern District of New York, and tribunals like International Centre for Settlement of Investment Disputes. Services include expert testimony in matters involving antitrust litigation similar to disputes presided over by judges in the United States Court of Appeals for the Second Circuit, securities litigation paralleling cases before the Securities and Exchange Commission, intellectual property disputes litigated in the United States District Court for the District of Delaware, and product liability claims filed in state courts such as those in California and Texas. The firm also supports merger reviews at agencies like the Department of Justice Antitrust Division and the Federal Trade Commission and provides regulatory economics for proceedings at the European Commission Directorate-General for Competition and national competition authorities such as the Competition and Markets Authority.

Notable Cases and Engagements

Engagements have included support for litigation associated with pharmaceutical patent disputes analogous to high-profile matters involving Merck, Johnson & Johnson, and Gilead Sciences; antitrust cases resembling challenges to mergers like AT&T–Time Warner and DowDuPont; and securities class actions comparable to cases involving Enron, WorldCom, and Lehman Brothers. The firm has provided health economic modeling in contexts related to vaccine policy debates like those encountered during the H1N1 pandemic and chronic disease studies intersecting with work at institutions such as Centers for Disease Control and Prevention. It has advised on valuation and damages in bankruptcy proceedings with parallels to filings in the United States Bankruptcy Court for the Southern District of New York and arbitration matters heard by panels affiliated with the International Chamber of Commerce.

Corporate Structure and Leadership

The firm is privately held and organized with regional offices across North America, Europe, and Asia, reflecting professional networks tied to universities such as Harvard University, Stanford University, University of California, Berkeley, and London School of Economics. Leadership has included founders and managing principals with academic appointments or affiliations to research centers at institutions like Massachusetts Institute of Technology, Dartmouth College, and Yale University. Staffing draws from alumni of programs at Columbia University and University of Chicago and collaborates with practitioners from firms such as McKinsey & Company and Boston Consulting Group on interdisciplinary engagements. Governance includes senior principals and practice leaders overseeing groups in health economics, antitrust, finance, and intellectual property.

Controversies and Criticism

Criticism of consultancy work in litigation has focused on issues similar to debates around expert witness practices in cases involving torts and mass tort litigation, discussions that echo scrutiny seen in matters with Big Tobacco and pharmaceutical settlements involving Vioxx. Critics have raised questions about conflicts of interest, transparency of methodologies, and the role of paid experts in influencing judicial and regulatory outcomes, themes common to discourse around expert testimony in courts like the United States District Court for the Northern District of California. Law journal commentary and investigative reporting have examined the relationships between consulting firms and law firms such as Gibson Dunn and Ropes & Gray, and regulatory commentators have called for clearer disclosure norms similar to reforms considered at the Federal Judicial Center and in congressional hearings.

Awards and Recognition

The firm and its leaders have received recognition in industry rankings and professional awards, appearing in listings by legal directories such as Chambers and Partners and financial publications that profile expert consulting practices. Individual principals have been honored for contributions to health economics and antitrust analysis by professional societies including the American Economic Association, AcademyHealth, and the International Society for Pharmacoeconomics and Outcomes Research. The firm’s work has been cited in academic journals affiliated with institutions like Oxford University and University of Chicago and featured in case studies at business schools such as Harvard Business School.

Category:Consulting firms in the United States